{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T22:48:58Z","timestamp":1766098138575,"version":"3.48.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cellimm.2025.105038","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:18:35Z","timestamp":1761592715000},"page":"105038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Differential heterologous immunological effects induced by ChAdOx1-S and BNT162b2 COVID-19 vaccines"],"prefix":"10.1016","volume":"418","author":[{"given":"Elisabeth A.","family":"Dulfer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00fcsra","family":"Geckin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn","family":"Zoodsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonie S.","family":"Helder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinout","family":"van Crevel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine S.","family":"van der Maat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Dom\u00ednguez-Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2025.105038_bb0005","article-title":"Covid-19: WHO declares end of global health emergency","volume":"381","author":"Wise","year":"2023","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.cellimm.2025.105038_bb0010","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"10","key":"10.1016\/j.cellimm.2025.105038_bb0015","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.18632\/aging.103344","article-title":"Why does COVID-19 disproportionately affect older people?","volume":"12","author":"Mueller","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"15","key":"10.1016\/j.cellimm.2025.105038_bb0020","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA Covid-19 vaccine in a Nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.cellimm.2025.105038_bb0025","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant","volume":"384","author":"Madhi","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2025.105038_bb0030","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"Bmj"},{"issue":"2","key":"10.1016\/j.cellimm.2025.105038_bb0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?","volume":"204","author":"Aaby","year":"2011","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.cellimm.2025.105038_bb0040","first-page":"185","article-title":"The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Wardhana","year":"2011","journal-title":"Acta Med. Indones."},{"issue":"5","key":"10.1016\/j.cellimm.2025.105038_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106733","article-title":"Randomized clinical trials of COVID-19 vaccines: Do adenovirus-vector vaccines have beneficial non-specific effects?","volume":"26","author":"Benn","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.cellimm.2025.105038_bb0050","doi-asserted-by":"crossref","unstructured":"Dulfer EA, Geckin B, Taks EJ, GeurtsvanKessel CH, Dijkstra H, van Emst L, et al. Timing and sequence of vaccination against COVID-19 and influenza (TACTIC): a single-blind, placebo-controlled randomized clinical trial. The Lancet Regional Health\u2013Europe. 2023;29.","DOI":"10.1016\/j.lanepe.2023.100628"},{"issue":"2","key":"10.1016\/j.cellimm.2025.105038_bb0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jviromet.2010.11.024","article-title":"Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza a H1N1 2009 virus","volume":"171","author":"Grund","year":"2011","journal-title":"J. Virol. Methods"},{"issue":"12","key":"10.1016\/j.cellimm.2025.105038_bb0060","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/CVI.00349-16","article-title":"In vitro experimental model of trained innate immunity in human primary monocytes","volume":"23","author":"Bekkering","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2025.105038_bb0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.cellimm.2025.105038_bb0070","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.cellimm.2025.105038_bb0075","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2021","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.cellimm.2025.105038_bb0080","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/aje\/kwp436","article-title":"Invited commentary: positivity in practice","volume":"171","author":"Westreich","year":"2010","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.cellimm.2025.105038_bb0085","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/imm.13470","article-title":"Siglec-5 is an inhibitory immune checkpoint molecule for human T cells","volume":"166","author":"Vuchkovska","year":"2022","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.cellimm.2025.105038_bb0090","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1038\/s41467-023-40918-2","article-title":"Engaging an HIV vaccine target through the acquisition of low B cell affinity","volume":"14","author":"Ronsard","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cellimm.2025.105038_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2023.100971","article-title":"A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines","volume":"4","author":"Ryan","year":"2023","journal-title":"Cell Reports Medicine"},{"key":"10.1016\/j.cellimm.2025.105038_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110168","article-title":"Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5\/14","volume":"144","author":"Murch","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"7347","key":"10.1016\/j.cellimm.2025.105038_bb0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature10098","article-title":"Global quantification of mammalian gene expression control","volume":"473","author":"Schwanh\u00e4usser","year":"2011","journal-title":"Nature"},{"issue":"48","key":"10.1016\/j.cellimm.2025.105038_bb0110","doi-asserted-by":"crossref","first-page":"7192","DOI":"10.1016\/j.vaccine.2023.10.034","article-title":"Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: implications for future pandemic vaccines","volume":"41","author":"Liu","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.cellimm.2025.105038_bb0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12916-022-02252-0","article-title":"Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2","volume":"20","author":"Ukey","year":"2022","journal-title":"BMC Med."},{"issue":"26","key":"10.1016\/j.cellimm.2025.105038_bb0120","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1016\/j.vaccine.2023.04.049","article-title":"COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs","volume":"41","author":"Jiang","year":"2023","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.cellimm.2025.105038_bb0125","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162581","article-title":"Trained immunity is induced in humans after immunization with an adenoviral vector COVID-19 vaccine","volume":"133","author":"Murphy","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"17","key":"10.1016\/j.cellimm.2025.105038_bb0130","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171742","article-title":"No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines","volume":"133","author":"Stevens","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2025.105038_bb0135","doi-asserted-by":"crossref","first-page":"1200789","DOI":"10.3389\/fcimb.2023.1200789","article-title":"COVID-19 inactivated and non-replicating viral vector vaccines induce regulatory training phenotype in human monocytes under epigenetic control","volume":"13","author":"Antunes","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"22","key":"10.1016\/j.cellimm.2025.105038_bb0140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163347","article-title":"Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells","volume":"7","author":"Yamaguchi","year":"2022","journal-title":"JCI Insight"},{"year":"2017","series-title":"Weekly Epidemiological Record (WER)","author":"WHO","key":"10.1016\/j.cellimm.2025.105038_bb0145"},{"issue":"4","key":"10.1016\/j.cellimm.2025.105038_bb0150","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/vaccines11040747","article-title":"COVID-19 mRNA vaccines: the molecular basis of some adverse events","volume":"11","author":"Giannotta","year":"2023","journal-title":"Vaccines"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874925001248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874925001248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T22:44:09Z","timestamp":1766097849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874925001248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"alternative-id":["S0008874925001248"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2025.105038","relation":{},"ISSN":["0008-8749"],"issn-type":[{"type":"print","value":"0008-8749"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential heterologous immunological effects induced by ChAdOx1-S and BNT162b2 COVID-19 vaccines","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2025.105038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105038"}}